Menstrual Bleeding

Shares of Repros Therapeutics Inc (NASDAQ: RPRX), a nano-cap biopharmaceutical company that focuses on the treatment of hormonal and reproductive system disorders, is surging higher by 60 percent. Repros Therapeutics reported after Tuesday's close that patients receiving 6 and 12 mg doses...